ANGION BIOMEDICA
Angion Biomedica is a clinical-stage organ restoration biopharmaceutical company focused on renal disease. Its investigational drug BB3 is entering phase 3 for delayed graft function following kidney transplant and phase 2 for acute kidney injury following open-heart surgery using cardiopulmonary bypass.
ANGION BIOMEDICA
Social Links:
Industry:
Biopharma Biotechnology Medical
Founded:
1998-01-01
Address:
Uniondale, New York, United States
Country:
United States
Website Url:
http://www.angion.com
Total Employee:
101+
Status:
Active
Contact:
5168691359
Email Addresses:
[email protected]
Total Funding:
84.27 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon WordPress Google Universal Analytics
Similar Organizations
Edgewise Therapeutics
Edgewise Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization.
Current Employees Featured
Founder
Stock Details
Investors List
Vifor Pharma
Vifor Pharma investment in Post-IPO Equity - Angion Biomedica
Formic Ventures
Formic Ventures investment in Venture Round - Angion Biomedica
U.S. Department of Defense
U.S. Department of Defense investment in Grant - Angion Biomedica
National Science Foundation
National Science Foundation investment in Grant - Angion Biomedica
Official Site Inspections
http://www.angion.com Semrush global rank: 2.67 M Semrush visits lastest month: 6.29 K
- Host name: 141.193.213.11
- IP address: 141.193.213.11
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
